Razaq, S. Et Al. 2021. Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?. Pediatric blood & cancer , vol.68 .

Razaq, S., Kara, M., & ÖZÇAKAR, L., (2021). Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?. Pediatric blood & cancer , vol.68.

Razaq, Sarah, MURAT KARA, And LEVENT ÖZÇAKAR. "Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?," Pediatric blood & cancer , vol.68, 2021

Razaq, Sarah Et Al. "Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?." Pediatric blood & cancer , vol.68, 2021

Razaq, S. Kara, M. And ÖZÇAKAR, L. (2021) . "Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?." Pediatric blood & cancer , vol.68.

@article{article, author={Sarah Razaq Et Al. }, title={Comment on: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma: Sarcopenia in children. A misnomer for muscle wasting or atrophy?}, journal={Pediatric blood & cancer}, year=2021}